Biotech Soars On New Price Target And Analyst Rating - InvestingChannel

Biotech Soars On New Price Target And Analyst Rating

A Massachusetts-based biotech company is turning heads on Thursday after it was announced that Webush Securities initiated coverage on the stock with an outperform rating and a $9.00 price target. Seeing that the stock closed at just $2.58 yesterday, naturally traders got excited!

Shares of Werewolf Therapeutics Inc. (Nasdaq:HOWL) rallied strongly on the new announcement, with shares of this small cap reaching gup to $3.134/share (+21.47%) at the session high. This move could be an indication of things to come given the magnitude of momentum the stock saw!

Werewolf Therapeutics Inc is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer.

Copyright © 2023 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com’s content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

]]>

Related posts

Advisors in Focus- January 6, 2021

Gavin Maguire

Advisors in Focus- February 15, 2021

Gavin Maguire

Advisors in Focus- February 22, 2021

Gavin Maguire

Advisors in Focus- February 28, 2021

Gavin Maguire

Advisors in Focus- March 18, 2021

Gavin Maguire

Advisors in Focus- March 21, 2021

Gavin Maguire